TIMOTHY SOUNDY: Open Payments
NPI 1053383539 · SIOUX FALLS, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,199 in 36 payments from 16 companies in 2025. Trend: 2023 $217 · 2024 $416 · 2025 $1,199
Food & beverage: $1,199
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $263 |
| Otsuka America Pharmaceutical, Inc. | 6 | $191 |
| Janssen Scientific Affairs, LLC | 1 | $129 |
| ACADIA Pharmaceuticals Inc | 1 | $115 |
| Travere Therapeutics, Inc. | 1 | $107 |
| Neurocrine BioSciences, Inc. | 4 | $66 |
| HARMONY BIOSCIENCES LLC | 4 | $64 |
| Alkermes, Inc. | 3 | $62 |
| Corium, LLC | 4 | $58 |
| Teva Pharmaceuticals USA, Inc. | 2 | $29 |
Products named: COBENFY, REXULTI, INVEGA SUSTENNA, NUPLAZID, Filspari, INGREZZA, WAKIX, ARISTADA.
Industry payments across SD — which companies pay providers there.
